These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 734357)

  • 21. Comparative study on biological effects of the guinea pig complement-peptide C3a and C3a-related synthetic oligopeptides.
    Bitter-Suermann D; Becker S; Meuer S; Schorlemmer HU; Hadding U; Andreatta R
    Mol Immunol; 1980 Oct; 17(10):1257-61. PubMed ID: 7464830
    [No Abstract]   [Full Text] [Related]  

  • 22. Amino acid sequence of guinea pig C3a anaphylatoxin.
    Gerard NP; Lively MO; Gerard C
    Protein Seq Data Anal; 1988; 1(6):473-8. PubMed ID: 3064079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of C3a anaphylatoxin receptor on guinea-pig macrophages.
    Murakami Y; Imamichi T; Nagasawa S
    Immunology; 1993 Aug; 79(4):633-8. PubMed ID: 8406589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotactic effects of the complement-derived peptides C3a, C3ai and C5a (classical anaphylatoxin) on rabbit and guinea-pig polymorphonuclear leukocytes.
    Damerau B; Grünefeld E; Vogt W
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov; 305(2):181-4. PubMed ID: 732894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaphylatoxin C3a induces rapid protein phosphorylation in guinea pig platelets.
    Fukuoka Y; Tachibana T; Yasui A
    Immunopharmacology; 1994; 28(2):95-104. PubMed ID: 8002292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.
    Glovsky MM; Hugli TE; Ishizaka T; Lichtenstein LM; Erickson BW
    J Clin Invest; 1979 Sep; 64(3):804-11. PubMed ID: 89118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaphylatoxin-induced release of histamine from in vitro perfused guinea pig kidney.
    Abdullah NA; Assem ES; Damerau B
    Agents Actions; 1988 Apr; 23(3-4):181-4. PubMed ID: 2455983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac dysfunction caused by purified human C3a anaphylatoxin.
    del Balzo UH; Levi R; Polley MJ
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):886-90. PubMed ID: 2579381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The active site of C3a anaphylatoxin.
    Caporale LH; Tippett PS; Erickson BW; Hugli TE
    J Biol Chem; 1980 Nov; 255(22):10758-63. PubMed ID: 6968751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic peptides as antagonists of the anaphylatoxin C3a.
    Kretzschmar T; Pohl M; Casaretto M; Przewosny M; Bautsch W; Klos A; Saunders D; Köhl J
    Eur J Biochem; 1992 Nov; 210(1):185-91. PubMed ID: 1446671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designing synthetic superagonists of C3a anaphylatoxin.
    Ember JA; Johansen NL; Hugli TE
    Biochemistry; 1991 Apr; 30(15):3603-12. PubMed ID: 2015217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of receptors to the anaphylatoxins on isolated cells.
    Fukuoka Y; Nielsen LP; Hugli TE
    Dermatologica; 1989; 179 Suppl 1():35-40. PubMed ID: 2528484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of biologically active C3a as fusion proteins.
    Fukuoka Y; Tachibana T; Yasui A
    Immunol Lett; 1993 Oct; 38(2):153-8. PubMed ID: 8294143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: alternative splicing in the large extracellular loop.
    Fukuoka Y; Ember JA; Hugli TE
    J Immunol; 1998 Sep; 161(6):2977-84. PubMed ID: 9743361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
    del Balzo U; Polley MJ; Levi R
    J Pharmacol Exp Ther; 1988 Sep; 246(3):911-6. PubMed ID: 2458450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the C5a receptor on guinea pig platelets.
    Kretzschmar T; Kahl K; Rech K; Bautsch W; Köhl J; Bitter-Suermann D
    Immunobiology; 1991 Nov; 183(5):418-32. PubMed ID: 1786990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.
    Hoffmann T; Böttger EC; Baum HP; Messner M; Hadding U; Bitter-Suermann D
    Clin Exp Immunol; 1988 Mar; 71(3):486-92. PubMed ID: 3260158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses.
    Morgan EL; Weigle WO; Hugli TE
    J Exp Med; 1982 May; 155(5):1412-26. PubMed ID: 6978374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C4a: the third anaphylatoxin of the human complement system.
    Gorski JP; Hugli TE; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5299-302. PubMed ID: 291947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
    Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
    J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.